João Eduardo Casalta Lopes
AuthID: R-000-WHS
61
TITLE: Cytotoxicity of Ascorbic Acid in a Human Colorectal Adenocarcinoma Cell Line (WiDr): In Vitro and In Vivo Studies Full Text
AUTHORS: Ana Catarina Mamede; Ana Salome Pires; Ana Margarida Abrantes ; Sonia Dorilde Tavares; Ana Cristina Gonçalves ; Joao Eduardo Casalta Lopes; Ana Bela Sarmento Ribeiro ; Jorge Manuel Maia; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, VOLUME: 64, ISSUE: 7
AUTHORS: Ana Catarina Mamede; Ana Salome Pires; Ana Margarida Abrantes ; Sonia Dorilde Tavares; Ana Cristina Gonçalves ; Joao Eduardo Casalta Lopes; Ana Bela Sarmento Ribeiro ; Jorge Manuel Maia; Maria Filomena Botelho ;
PUBLISHED: 2012, SOURCE: NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, VOLUME: 64, ISSUE: 7
62
TITLE: MDR modulation in adenocarcinoma cell lines: nuclear medicine as an important approach Full Text
AUTHORS: Casalta Lopes, J; Abrantes, AM ; Rio, J; Laranjo, Mafalda ; Oliveiros, B; Goncalves, C; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2010, SOURCE: 21st Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 8, ISSUE: 5
AUTHORS: Casalta Lopes, J; Abrantes, AM ; Rio, J; Laranjo, Mafalda ; Oliveiros, B; Goncalves, C; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2010, SOURCE: 21st Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 8, ISSUE: 5
INDEXED IN:
WOS

63
TITLE: MIBI as MDR probe: in vitro studies in two human colorectal adenocarcinoma cell lines Full Text
AUTHORS: Casalta Lopes, JE; Abrantes, AM ; Laranjo, Mafalda ; Ana Cristina Gonçalves ; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2008, SOURCE: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 35
AUTHORS: Casalta Lopes, JE; Abrantes, AM ; Laranjo, Mafalda ; Ana Cristina Gonçalves ; Sarmento Ribeiro, AB; Maria Filomena Botelho ;
PUBLISHED: 2008, SOURCE: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, VOLUME: 35
INDEXED IN:
WOS
